SlideShare uma empresa Scribd logo
1 de 35
NICOLA SMITH NATIONAL ASPERGILLOSIS CENTRE UHSM MANCHESTER Support Meeting for Aspergillosis Patients Fungal Research Trust
Nicola Smith The University of Manchester, Manchester Academic Health Science Centre, University Hospital of South Manchester, UK Genetic Susceptibility to Aspergillosis
Introduction:  Aspergillosis (1) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Genetic Susceptibility in Aspergillosis ,[object Object],[object Object],[object Object],[object Object],[object Object]
DNA, Genes & Proteins ,[object Object],[object Object],[object Object],Fig: http://www.bioteach.ubc.ca/Bioinformatics/humangenome  ,[object Object],[object Object],[object Object]
Gene Expression (1) ,[object Object],[object Object],[object Object],[object Object]
Gene Expression (2) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Immune cell Protein Germ
Gene Expression:  Do the cells of aspergillosis patients respond differently to those from healthy volunteers?
Gene Expression  and Aspergillosis (1) ,[object Object],[object Object],[object Object],[object Object],Aspergillus Macrophage
Gene Expression  and Aspergillosis (2) ,[object Object],[object Object],[object Object],[object Object]
Timepoints for gene expression (1) Gene expression is measured at 30min, 1hr, 3hr, 6hr and 9hr – how does this relate to the fungus? Fungal growth: resting conidia (RC)    germinating conidia (GC)    germtube (GT)    hyphae (H) Counted the amount of fungus at each stage over time
Timepoints for gene expression (2) Gene expression is measured at 30min, 1hr, 3hr, 6hr and 9hr – how does this relate to the fungus? 3hr – mostly resting conidia 6hr – mostly germtubes 9hr – mostly hyphae
Method Ficoll prep PBMCs stored in liquid nitrogen Cultured for 12-15 days to differentiate to macrophages (~2x10 5 ) 24well plate – one plate per timepoint 0hr timepoint –  investigate gene expression Aspergillus  spores added (4x10 5 ) 30min, 1hr, 3hr, 6hr, 9hr timepoints -  Investigate gene expression Macrophages and  Aspergillus  cultured together Heparinised Blood Macrophages PBMCs thawed and  plated out (2x10 6 ) PBMCs Ficoll prepped blood Plasma Ficoll Granulocytes
Gene Expression Results I studied the expression of 84 genes!
RED: more expression in ABPA (2) GREEN: less expression in ABPA (12) Expression before Exposure: ABPA ABPA 0hr vs Asthma 0hr >2-fold higher expression in ABPA >2-fold lower expression in ABPA
RED: more expression in CCPA (4) GREEN: less expression in CCPA (5) CCPA 0hr vs Healthy 0hr >2-fold higher expression in CCPA >2-fold lower expression in CCPA Expression before Exposure: CCPA
[object Object],[object Object],[object Object],[object Object],[object Object],Expression before Exposure: ABPA and CCPA
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Expression before Exposure:  TLRs
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Expression before Exposure:  IL1 pathway
[object Object],[object Object],[object Object],Expression over time:  IL1 pathway IL6 IL1A IL1B
[object Object],[object Object],Expression over time
Genetic Variation:  Are there similar differences in the genes (DNA)?
Genetic Variation ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],ATGGGTAATGCCATGTCAC = normal protein ATGGGTAA C GCCATGTCAC = more protein ATGG A TAATGCCATGTCAC = non-functional protein
Example: STAT6
Example: MBL ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Genetic Variation and Disease ,[object Object],[object Object],[object Object],[object Object],[object Object]
Genetic Variation Results (1) CCPA 0hr vs Healthy 0hr >2-fold higher expression in ABPA >2-fold lower expression in CCPA ,[object Object],[object Object],[object Object],[object Object]
Genetic Variation Results (2) ,[object Object],[object Object],[object Object],IL6
Genetic Variation Results (3) ,[object Object],[object Object],[object Object],ABPA 0hr vs Asthma 0hr >2-fold higher expression in ABPA >2-fold lower expression in ABPA
Genetic Variation Results (4) ,[object Object],[object Object],[object Object],[object Object],[object Object]
Genetic Variation Results (5) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
So what? ,[object Object],[object Object],[object Object],[object Object]
How? ,[object Object],[object Object],[object Object],[object Object]
Summary ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Acknowlegements ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Mais conteúdo relacionado

Mais procurados

HIV Therapeutic vaccines
HIV Therapeutic vaccinesHIV Therapeutic vaccines
HIV Therapeutic vaccinesreza mozafari
 
DEVELOPMENT OF FUSION PROTEIN OF ANTIGEN 85B AND ESAT-6 AS SUBUNIT VACCINE A...
DEVELOPMENT OF FUSION PROTEIN OF ANTIGEN 85B AND ESAT-6 AS SUBUNIT VACCINE A...DEVELOPMENT OF FUSION PROTEIN OF ANTIGEN 85B AND ESAT-6 AS SUBUNIT VACCINE A...
DEVELOPMENT OF FUSION PROTEIN OF ANTIGEN 85B AND ESAT-6 AS SUBUNIT VACCINE A...Esakki Muthu Lakshmi Venkatesh
 
Nano Curcumin Effect in Nuclear Factor Kappa B (NFκB), Tumor Necrosis Factor-...
Nano Curcumin Effect in Nuclear Factor Kappa B (NFκB), Tumor Necrosis Factor-...Nano Curcumin Effect in Nuclear Factor Kappa B (NFκB), Tumor Necrosis Factor-...
Nano Curcumin Effect in Nuclear Factor Kappa B (NFκB), Tumor Necrosis Factor-...Didit Pramudhito
 
characterization of FQ Non-susceptible S. Pyogenes
characterization of FQ Non-susceptible S. Pyogenescharacterization of FQ Non-susceptible S. Pyogenes
characterization of FQ Non-susceptible S. Pyogenescamilomesa22
 
identification and characterization of FQ-non-susceptable S. Pyogenes
identification and characterization of FQ-non-susceptable S. Pyogenesidentification and characterization of FQ-non-susceptable S. Pyogenes
identification and characterization of FQ-non-susceptable S. Pyogenescamilomesa22
 
Comparing internalization in cells expressing the wild-type and
Comparing internalization in cells expressing the wild-type andComparing internalization in cells expressing the wild-type and
Comparing internalization in cells expressing the wild-type andAndalus Ayaz
 
cytokine-production-and-human-cytomegalovirus-load-in-allogeneic-hematopoieti...
cytokine-production-and-human-cytomegalovirus-load-in-allogeneic-hematopoieti...cytokine-production-and-human-cytomegalovirus-load-in-allogeneic-hematopoieti...
cytokine-production-and-human-cytomegalovirus-load-in-allogeneic-hematopoieti...Peertechz Publications
 
Hiv envelope gp120 alters t cell receptor mobilization in the immunological s...
Hiv envelope gp120 alters t cell receptor mobilization in the immunological s...Hiv envelope gp120 alters t cell receptor mobilization in the immunological s...
Hiv envelope gp120 alters t cell receptor mobilization in the immunological s...Md. Shabab Mehebub
 
Bee venom in Parkinson's Disease(PD)
Bee venom in Parkinson's Disease(PD)Bee venom in Parkinson's Disease(PD)
Bee venom in Parkinson's Disease(PD)SAKEEL AHMED
 
201911 - Conte - Asma eosinofilico: i farmaci biologici che contrastano l'azi...
201911 - Conte - Asma eosinofilico: i farmaci biologici che contrastano l'azi...201911 - Conte - Asma eosinofilico: i farmaci biologici che contrastano l'azi...
201911 - Conte - Asma eosinofilico: i farmaci biologici che contrastano l'azi...Asmallergie
 
<마더세이프라운드> 제일병원 양광문 교수
<마더세이프라운드> 제일병원 양광문 교수<마더세이프라운드> 제일병원 양광문 교수
<마더세이프라운드> 제일병원 양광문 교수mothersafe
 

Mais procurados (20)

HIV Therapeutic vaccines
HIV Therapeutic vaccinesHIV Therapeutic vaccines
HIV Therapeutic vaccines
 
Penn
PennPenn
Penn
 
Hiv Tb Vaccines
Hiv Tb VaccinesHiv Tb Vaccines
Hiv Tb Vaccines
 
DEVELOPMENT OF FUSION PROTEIN OF ANTIGEN 85B AND ESAT-6 AS SUBUNIT VACCINE A...
DEVELOPMENT OF FUSION PROTEIN OF ANTIGEN 85B AND ESAT-6 AS SUBUNIT VACCINE A...DEVELOPMENT OF FUSION PROTEIN OF ANTIGEN 85B AND ESAT-6 AS SUBUNIT VACCINE A...
DEVELOPMENT OF FUSION PROTEIN OF ANTIGEN 85B AND ESAT-6 AS SUBUNIT VACCINE A...
 
Nano Curcumin Effect in Nuclear Factor Kappa B (NFκB), Tumor Necrosis Factor-...
Nano Curcumin Effect in Nuclear Factor Kappa B (NFκB), Tumor Necrosis Factor-...Nano Curcumin Effect in Nuclear Factor Kappa B (NFκB), Tumor Necrosis Factor-...
Nano Curcumin Effect in Nuclear Factor Kappa B (NFκB), Tumor Necrosis Factor-...
 
Lary nel abao nc-nga mice revised report
Lary nel abao nc-nga mice revised reportLary nel abao nc-nga mice revised report
Lary nel abao nc-nga mice revised report
 
characterization of FQ Non-susceptible S. Pyogenes
characterization of FQ Non-susceptible S. Pyogenescharacterization of FQ Non-susceptible S. Pyogenes
characterization of FQ Non-susceptible S. Pyogenes
 
identification and characterization of FQ-non-susceptable S. Pyogenes
identification and characterization of FQ-non-susceptable S. Pyogenesidentification and characterization of FQ-non-susceptable S. Pyogenes
identification and characterization of FQ-non-susceptable S. Pyogenes
 
Comparing internalization in cells expressing the wild-type and
Comparing internalization in cells expressing the wild-type andComparing internalization in cells expressing the wild-type and
Comparing internalization in cells expressing the wild-type and
 
cytokine-production-and-human-cytomegalovirus-load-in-allogeneic-hematopoieti...
cytokine-production-and-human-cytomegalovirus-load-in-allogeneic-hematopoieti...cytokine-production-and-human-cytomegalovirus-load-in-allogeneic-hematopoieti...
cytokine-production-and-human-cytomegalovirus-load-in-allogeneic-hematopoieti...
 
Hiv envelope gp120 alters t cell receptor mobilization in the immunological s...
Hiv envelope gp120 alters t cell receptor mobilization in the immunological s...Hiv envelope gp120 alters t cell receptor mobilization in the immunological s...
Hiv envelope gp120 alters t cell receptor mobilization in the immunological s...
 
GKA deel 2 college 15
GKA deel 2 college 15GKA deel 2 college 15
GKA deel 2 college 15
 
Bee venom in Parkinson's Disease(PD)
Bee venom in Parkinson's Disease(PD)Bee venom in Parkinson's Disease(PD)
Bee venom in Parkinson's Disease(PD)
 
201911 - Conte - Asma eosinofilico: i farmaci biologici che contrastano l'azi...
201911 - Conte - Asma eosinofilico: i farmaci biologici che contrastano l'azi...201911 - Conte - Asma eosinofilico: i farmaci biologici che contrastano l'azi...
201911 - Conte - Asma eosinofilico: i farmaci biologici che contrastano l'azi...
 
Musc Surp 2011 1
Musc Surp 2011 1Musc Surp 2011 1
Musc Surp 2011 1
 
Canopus Biopharma Inc
Canopus Biopharma IncCanopus Biopharma Inc
Canopus Biopharma Inc
 
abstract
abstractabstract
abstract
 
<마더세이프라운드> 제일병원 양광문 교수
<마더세이프라운드> 제일병원 양광문 교수<마더세이프라운드> 제일병원 양광문 교수
<마더세이프라운드> 제일병원 양광문 교수
 
GKA deel 2 college 8
GKA deel 2 college 8GKA deel 2 college 8
GKA deel 2 college 8
 
Bacteria
BacteriaBacteria
Bacteria
 

Destaque

Proficiency 2 Astronomy Science
Proficiency 2 Astronomy ScienceProficiency 2 Astronomy Science
Proficiency 2 Astronomy Sciencebrotjes15
 
Vdgp voorraad in de vingers
Vdgp voorraad in de vingersVdgp voorraad in de vingers
Vdgp voorraad in de vingersTony Hardenberg
 
Innovatielab zorg, onderwijs en veiligheid
Innovatielab zorg, onderwijs en veiligheidInnovatielab zorg, onderwijs en veiligheid
Innovatielab zorg, onderwijs en veiligheidTony Hardenberg
 
V kontakte september_2010
V kontakte september_2010V kontakte september_2010
V kontakte september_2010denisogr
 
It is all about me
It is all about meIt is all about me
It is all about me1YQBeu
 
Borja´s presentation
Borja´s presentationBorja´s presentation
Borja´s presentationBorjaspdp
 
Skepsis congres 2015 - Het begrip deskundigheid - Frans van Lunteren
Skepsis congres 2015 - Het begrip deskundigheid - Frans van LunterenSkepsis congres 2015 - Het begrip deskundigheid - Frans van Lunteren
Skepsis congres 2015 - Het begrip deskundigheid - Frans van LunterenMaarten Koller
 
أثربرنامج هيا نلعب على تعلم تلاميذ الصف
أثربرنامج هيا نلعب على تعلم تلاميذ    الصفأثربرنامج هيا نلعب على تعلم تلاميذ    الصف
أثربرنامج هيا نلعب على تعلم تلاميذ الصفlsemairi
 
Terminkalender
TerminkalenderTerminkalender
TerminkalenderAnke Berns
 
Pharmacologic principles
Pharmacologic principlesPharmacologic principles
Pharmacologic principlesUmair hanif
 
101 lecture 17 oligopoly
101 lecture 17 oligopoly101 lecture 17 oligopoly
101 lecture 17 oligopolyGale Pooley
 
Aspergillosis Patient Support Meeting March 2011 - Jane Mabey Gilsenan
Aspergillosis Patient Support Meeting March 2011 - Jane Mabey GilsenanAspergillosis Patient Support Meeting March 2011 - Jane Mabey Gilsenan
Aspergillosis Patient Support Meeting March 2011 - Jane Mabey GilsenanGraham Atherton
 
ITP events portfolio by Preeta Panicker
ITP events portfolio by Preeta PanickerITP events portfolio by Preeta Panicker
ITP events portfolio by Preeta PanickerPreeta Panicker
 
6 oct esport i valors
6 oct esport i valors6 oct esport i valors
6 oct esport i valorsxaviruiz74
 

Destaque (20)

AR Browsers
AR BrowsersAR Browsers
AR Browsers
 
Proficiency 2 Astronomy Science
Proficiency 2 Astronomy ScienceProficiency 2 Astronomy Science
Proficiency 2 Astronomy Science
 
Vdgp voorraad in de vingers
Vdgp voorraad in de vingersVdgp voorraad in de vingers
Vdgp voorraad in de vingers
 
Innovatielab zorg, onderwijs en veiligheid
Innovatielab zorg, onderwijs en veiligheidInnovatielab zorg, onderwijs en veiligheid
Innovatielab zorg, onderwijs en veiligheid
 
V kontakte september_2010
V kontakte september_2010V kontakte september_2010
V kontakte september_2010
 
It is all about me
It is all about meIt is all about me
It is all about me
 
Club asteria
Club asteriaClub asteria
Club asteria
 
Exam 1 review
Exam 1 reviewExam 1 review
Exam 1 review
 
Borja´s presentation
Borja´s presentationBorja´s presentation
Borja´s presentation
 
pw
pwpw
pw
 
Skepsis congres 2015 - Het begrip deskundigheid - Frans van Lunteren
Skepsis congres 2015 - Het begrip deskundigheid - Frans van LunterenSkepsis congres 2015 - Het begrip deskundigheid - Frans van Lunteren
Skepsis congres 2015 - Het begrip deskundigheid - Frans van Lunteren
 
أثربرنامج هيا نلعب على تعلم تلاميذ الصف
أثربرنامج هيا نلعب على تعلم تلاميذ    الصفأثربرنامج هيا نلعب على تعلم تلاميذ    الصف
أثربرنامج هيا نلعب على تعلم تلاميذ الصف
 
Dhvm
DhvmDhvm
Dhvm
 
Terminkalender
TerminkalenderTerminkalender
Terminkalender
 
Pharmacologic principles
Pharmacologic principlesPharmacologic principles
Pharmacologic principles
 
101 lecture 17 oligopoly
101 lecture 17 oligopoly101 lecture 17 oligopoly
101 lecture 17 oligopoly
 
Aspergillosis Patient Support Meeting March 2011 - Jane Mabey Gilsenan
Aspergillosis Patient Support Meeting March 2011 - Jane Mabey GilsenanAspergillosis Patient Support Meeting March 2011 - Jane Mabey Gilsenan
Aspergillosis Patient Support Meeting March 2011 - Jane Mabey Gilsenan
 
ITP events portfolio by Preeta Panicker
ITP events portfolio by Preeta PanickerITP events portfolio by Preeta Panicker
ITP events portfolio by Preeta Panicker
 
6 oct esport i valors
6 oct esport i valors6 oct esport i valors
6 oct esport i valors
 
Conquest of paradise
Conquest of paradiseConquest of paradise
Conquest of paradise
 

Semelhante a Aspergillosis Patients Support Meeting August 2011

Src jbbr-20-120 Dr. ihsan edan abdulkareem alsaimary PROFESSOR IN MEDICAL M...
Src jbbr-20-120  Dr. ihsan edan abdulkareem alsaimary  PROFESSOR IN MEDICAL M...Src jbbr-20-120  Dr. ihsan edan abdulkareem alsaimary  PROFESSOR IN MEDICAL M...
Src jbbr-20-120 Dr. ihsan edan abdulkareem alsaimary PROFESSOR IN MEDICAL M...dr.Ihsan alsaimary
 
Information for doctors
Information for doctorsInformation for doctors
Information for doctorsCereal Inc.
 
Management of Chronic Pulmonary Aspergillosis and IgE for the Layperson
Management of Chronic Pulmonary Aspergillosis and IgE for the LaypersonManagement of Chronic Pulmonary Aspergillosis and IgE for the Layperson
Management of Chronic Pulmonary Aspergillosis and IgE for the LaypersonGraham Atherton
 
Research Updates in SJIA & MAS - Grant Schulert
Research Updates in SJIA & MAS - Grant SchulertResearch Updates in SJIA & MAS - Grant Schulert
Research Updates in SJIA & MAS - Grant SchulertSystemic JIA Foundation
 
Mycobacterium tuberculosis
Mycobacterium tuberculosisMycobacterium tuberculosis
Mycobacterium tuberculosisarchana gautam
 
New Treatments for Lupus by Daniel J. Wallace, MD
New Treatments for Lupus by Daniel J. Wallace, MDNew Treatments for Lupus by Daniel J. Wallace, MD
New Treatments for Lupus by Daniel J. Wallace, MDLupusNY
 
Systemic Lupus Erythematosus (SLE)
Systemic Lupus Erythematosus (SLE)Systemic Lupus Erythematosus (SLE)
Systemic Lupus Erythematosus (SLE)Arwa M. Amin
 
Dr Paul Bowyer - Aspergillosis Study Day May 1st 2012
Dr Paul Bowyer - Aspergillosis Study Day May 1st 2012Dr Paul Bowyer - Aspergillosis Study Day May 1st 2012
Dr Paul Bowyer - Aspergillosis Study Day May 1st 2012Graham Atherton
 
Biologic Therapy
Biologic TherapyBiologic Therapy
Biologic Therapydrmomusa
 
Aspergillosis Patient Support Meeting July 2011 - Sue Howard
Aspergillosis Patient Support Meeting July 2011 - Sue HowardAspergillosis Patient Support Meeting July 2011 - Sue Howard
Aspergillosis Patient Support Meeting July 2011 - Sue HowardGraham Atherton
 
Fungal Research Trust 20th Anniversary Meeting June 2011 - Dr Sue Howard
Fungal Research Trust 20th Anniversary Meeting June 2011 - Dr Sue HowardFungal Research Trust 20th Anniversary Meeting June 2011 - Dr Sue Howard
Fungal Research Trust 20th Anniversary Meeting June 2011 - Dr Sue HowardGraham Atherton
 
Antimicrobial regimen selection
Antimicrobial regimen selectionAntimicrobial regimen selection
Antimicrobial regimen selectionTsegaye Melaku
 
Fusion of Chinese and Western medicine perspectives for the diagnosis of rheu...
Fusion of Chinese and Western medicine perspectives for the diagnosis of rheu...Fusion of Chinese and Western medicine perspectives for the diagnosis of rheu...
Fusion of Chinese and Western medicine perspectives for the diagnosis of rheu...Wietmarschen
 
Open Source Pharma /Genomics and clinical practice / Prof Hosur
Open Source Pharma /Genomics and clinical practice / Prof Hosur Open Source Pharma /Genomics and clinical practice / Prof Hosur
Open Source Pharma /Genomics and clinical practice / Prof Hosur opensourcepharmafound
 
Connective Tissue Diseases
Connective Tissue DiseasesConnective Tissue Diseases
Connective Tissue Diseaseskatejohnpunag
 
Asthma_Medication.pdf
Asthma_Medication.pdfAsthma_Medication.pdf
Asthma_Medication.pdfRutvikShah52
 
Dr. Esteban Domingo: Respuesta del virus de la hepatitis C a inhibidores. Inf...
Dr. Esteban Domingo: Respuesta del virus de la hepatitis C a inhibidores. Inf...Dr. Esteban Domingo: Respuesta del virus de la hepatitis C a inhibidores. Inf...
Dr. Esteban Domingo: Respuesta del virus de la hepatitis C a inhibidores. Inf...Vall d'Hebron Institute of Research (VHIR)
 

Semelhante a Aspergillosis Patients Support Meeting August 2011 (20)

Diaz-Arrastia, Ramon
Diaz-Arrastia, RamonDiaz-Arrastia, Ramon
Diaz-Arrastia, Ramon
 
Src jbbr-20-120 Dr. ihsan edan abdulkareem alsaimary PROFESSOR IN MEDICAL M...
Src jbbr-20-120  Dr. ihsan edan abdulkareem alsaimary  PROFESSOR IN MEDICAL M...Src jbbr-20-120  Dr. ihsan edan abdulkareem alsaimary  PROFESSOR IN MEDICAL M...
Src jbbr-20-120 Dr. ihsan edan abdulkareem alsaimary PROFESSOR IN MEDICAL M...
 
Information for doctors
Information for doctorsInformation for doctors
Information for doctors
 
Management of Chronic Pulmonary Aspergillosis and IgE for the Layperson
Management of Chronic Pulmonary Aspergillosis and IgE for the LaypersonManagement of Chronic Pulmonary Aspergillosis and IgE for the Layperson
Management of Chronic Pulmonary Aspergillosis and IgE for the Layperson
 
Research Updates in SJIA & MAS - Grant Schulert
Research Updates in SJIA & MAS - Grant SchulertResearch Updates in SJIA & MAS - Grant Schulert
Research Updates in SJIA & MAS - Grant Schulert
 
Mycobacterium tuberculosis
Mycobacterium tuberculosisMycobacterium tuberculosis
Mycobacterium tuberculosis
 
New Treatments for Lupus by Daniel J. Wallace, MD
New Treatments for Lupus by Daniel J. Wallace, MDNew Treatments for Lupus by Daniel J. Wallace, MD
New Treatments for Lupus by Daniel J. Wallace, MD
 
Systemic Lupus Erythematosus (SLE)
Systemic Lupus Erythematosus (SLE)Systemic Lupus Erythematosus (SLE)
Systemic Lupus Erythematosus (SLE)
 
ICN Victoria: Cornely on "Being a Fun-gi in ICU"
ICN Victoria: Cornely on "Being a Fun-gi in ICU"ICN Victoria: Cornely on "Being a Fun-gi in ICU"
ICN Victoria: Cornely on "Being a Fun-gi in ICU"
 
Dr Paul Bowyer - Aspergillosis Study Day May 1st 2012
Dr Paul Bowyer - Aspergillosis Study Day May 1st 2012Dr Paul Bowyer - Aspergillosis Study Day May 1st 2012
Dr Paul Bowyer - Aspergillosis Study Day May 1st 2012
 
Seminario biomol.pdf
Seminario biomol.pdfSeminario biomol.pdf
Seminario biomol.pdf
 
Biologic Therapy
Biologic TherapyBiologic Therapy
Biologic Therapy
 
Aspergillosis Patient Support Meeting July 2011 - Sue Howard
Aspergillosis Patient Support Meeting July 2011 - Sue HowardAspergillosis Patient Support Meeting July 2011 - Sue Howard
Aspergillosis Patient Support Meeting July 2011 - Sue Howard
 
Fungal Research Trust 20th Anniversary Meeting June 2011 - Dr Sue Howard
Fungal Research Trust 20th Anniversary Meeting June 2011 - Dr Sue HowardFungal Research Trust 20th Anniversary Meeting June 2011 - Dr Sue Howard
Fungal Research Trust 20th Anniversary Meeting June 2011 - Dr Sue Howard
 
Antimicrobial regimen selection
Antimicrobial regimen selectionAntimicrobial regimen selection
Antimicrobial regimen selection
 
Fusion of Chinese and Western medicine perspectives for the diagnosis of rheu...
Fusion of Chinese and Western medicine perspectives for the diagnosis of rheu...Fusion of Chinese and Western medicine perspectives for the diagnosis of rheu...
Fusion of Chinese and Western medicine perspectives for the diagnosis of rheu...
 
Open Source Pharma /Genomics and clinical practice / Prof Hosur
Open Source Pharma /Genomics and clinical practice / Prof Hosur Open Source Pharma /Genomics and clinical practice / Prof Hosur
Open Source Pharma /Genomics and clinical practice / Prof Hosur
 
Connective Tissue Diseases
Connective Tissue DiseasesConnective Tissue Diseases
Connective Tissue Diseases
 
Asthma_Medication.pdf
Asthma_Medication.pdfAsthma_Medication.pdf
Asthma_Medication.pdf
 
Dr. Esteban Domingo: Respuesta del virus de la hepatitis C a inhibidores. Inf...
Dr. Esteban Domingo: Respuesta del virus de la hepatitis C a inhibidores. Inf...Dr. Esteban Domingo: Respuesta del virus de la hepatitis C a inhibidores. Inf...
Dr. Esteban Domingo: Respuesta del virus de la hepatitis C a inhibidores. Inf...
 

Mais de Graham Atherton

Offline community, VOICE focus meeting.
Offline community, VOICE focus meeting.Offline community, VOICE focus meeting.
Offline community, VOICE focus meeting.Graham Atherton
 
Offline Patients Quarterly Newsletter
Offline Patients Quarterly NewsletterOffline Patients Quarterly Newsletter
Offline Patients Quarterly NewsletterGraham Atherton
 
Pseudomonas infections and a new type of antifungal drug
Pseudomonas infections and a new type of antifungal drugPseudomonas infections and a new type of antifungal drug
Pseudomonas infections and a new type of antifungal drugGraham Atherton
 
Aspergillosis Support Group Christmas Quiz 2013
Aspergillosis Support Group Christmas Quiz 2013Aspergillosis Support Group Christmas Quiz 2013
Aspergillosis Support Group Christmas Quiz 2013Graham Atherton
 
Poetry facilitates awareness, Rupert Everett & Katie Melua support. How antif...
Poetry facilitates awareness, Rupert Everett & Katie Melua support. How antif...Poetry facilitates awareness, Rupert Everett & Katie Melua support. How antif...
Poetry facilitates awareness, Rupert Everett & Katie Melua support. How antif...Graham Atherton
 
Involving Patients (and carers) in research at NWLC & NAC
Involving Patients (and carers) in research at NWLC & NACInvolving Patients (and carers) in research at NWLC & NAC
Involving Patients (and carers) in research at NWLC & NACGraham Atherton
 
Comparing parts of UK & US Healthcare systems, IgG explained
Comparing parts of UK & US Healthcare systems, IgG explainedComparing parts of UK & US Healthcare systems, IgG explained
Comparing parts of UK & US Healthcare systems, IgG explainedGraham Atherton
 
NHS New Structure and Heatwaves
NHS New Structure and HeatwavesNHS New Structure and Heatwaves
NHS New Structure and HeatwavesGraham Atherton
 
Stress and breathlessness
Stress and breathlessnessStress and breathlessness
Stress and breathlessnessGraham Atherton
 
New antifungals and TB research
New antifungals and TB researchNew antifungals and TB research
New antifungals and TB researchGraham Atherton
 
Creative Writing Projects at the National Aspergillosis Centre
Creative Writing Projects at the National Aspergillosis CentreCreative Writing Projects at the National Aspergillosis Centre
Creative Writing Projects at the National Aspergillosis CentreGraham Atherton
 
Maintaining or Improving your health status in CPA (Khaled Al-shair)
Maintaining or Improving your health status in CPA (Khaled Al-shair)Maintaining or Improving your health status in CPA (Khaled Al-shair)
Maintaining or Improving your health status in CPA (Khaled Al-shair)Graham Atherton
 
Antifungals, Quality of Life study and Inhalers
Antifungals, Quality of Life study and InhalersAntifungals, Quality of Life study and Inhalers
Antifungals, Quality of Life study and InhalersGraham Atherton
 
Aspergillosis Patients Meeting Christmas Quiz December 2012
Aspergillosis Patients Meeting Christmas Quiz December 2012Aspergillosis Patients Meeting Christmas Quiz December 2012
Aspergillosis Patients Meeting Christmas Quiz December 2012Graham Atherton
 
Aches and Pains, Everyday Moulds & Facemasks
Aches and Pains, Everyday Moulds & FacemasksAches and Pains, Everyday Moulds & Facemasks
Aches and Pains, Everyday Moulds & FacemasksGraham Atherton
 
Latest Aspergillosis Research at NAC
Latest Aspergillosis Research at NACLatest Aspergillosis Research at NAC
Latest Aspergillosis Research at NACGraham Atherton
 
Some of the latest progress for the prevention, diagnosis and treatment of as...
Some of the latest progress for the prevention, diagnosis and treatment of as...Some of the latest progress for the prevention, diagnosis and treatment of as...
Some of the latest progress for the prevention, diagnosis and treatment of as...Graham Atherton
 
Chronic Cough: What it is and how to try to reduce its impact on your life
Chronic Cough: What it is and how to try to reduce its impact on your lifeChronic Cough: What it is and how to try to reduce its impact on your life
Chronic Cough: What it is and how to try to reduce its impact on your lifeGraham Atherton
 
How to give up smoking at UHSM
How to give up smoking at UHSMHow to give up smoking at UHSM
How to give up smoking at UHSMGraham Atherton
 

Mais de Graham Atherton (20)

Offline community, VOICE focus meeting.
Offline community, VOICE focus meeting.Offline community, VOICE focus meeting.
Offline community, VOICE focus meeting.
 
Offline Patients Quarterly Newsletter
Offline Patients Quarterly NewsletterOffline Patients Quarterly Newsletter
Offline Patients Quarterly Newsletter
 
Pseudomonas infections and a new type of antifungal drug
Pseudomonas infections and a new type of antifungal drugPseudomonas infections and a new type of antifungal drug
Pseudomonas infections and a new type of antifungal drug
 
Aspergillosis Support Group Christmas Quiz 2013
Aspergillosis Support Group Christmas Quiz 2013Aspergillosis Support Group Christmas Quiz 2013
Aspergillosis Support Group Christmas Quiz 2013
 
Poetry facilitates awareness, Rupert Everett & Katie Melua support. How antif...
Poetry facilitates awareness, Rupert Everett & Katie Melua support. How antif...Poetry facilitates awareness, Rupert Everett & Katie Melua support. How antif...
Poetry facilitates awareness, Rupert Everett & Katie Melua support. How antif...
 
Involving Patients (and carers) in research at NWLC & NAC
Involving Patients (and carers) in research at NWLC & NACInvolving Patients (and carers) in research at NWLC & NAC
Involving Patients (and carers) in research at NWLC & NAC
 
Comparing parts of UK & US Healthcare systems, IgG explained
Comparing parts of UK & US Healthcare systems, IgG explainedComparing parts of UK & US Healthcare systems, IgG explained
Comparing parts of UK & US Healthcare systems, IgG explained
 
NHS New Structure and Heatwaves
NHS New Structure and HeatwavesNHS New Structure and Heatwaves
NHS New Structure and Heatwaves
 
Carers and Damp Homes
Carers and Damp HomesCarers and Damp Homes
Carers and Damp Homes
 
Stress and breathlessness
Stress and breathlessnessStress and breathlessness
Stress and breathlessness
 
New antifungals and TB research
New antifungals and TB researchNew antifungals and TB research
New antifungals and TB research
 
Creative Writing Projects at the National Aspergillosis Centre
Creative Writing Projects at the National Aspergillosis CentreCreative Writing Projects at the National Aspergillosis Centre
Creative Writing Projects at the National Aspergillosis Centre
 
Maintaining or Improving your health status in CPA (Khaled Al-shair)
Maintaining or Improving your health status in CPA (Khaled Al-shair)Maintaining or Improving your health status in CPA (Khaled Al-shair)
Maintaining or Improving your health status in CPA (Khaled Al-shair)
 
Antifungals, Quality of Life study and Inhalers
Antifungals, Quality of Life study and InhalersAntifungals, Quality of Life study and Inhalers
Antifungals, Quality of Life study and Inhalers
 
Aspergillosis Patients Meeting Christmas Quiz December 2012
Aspergillosis Patients Meeting Christmas Quiz December 2012Aspergillosis Patients Meeting Christmas Quiz December 2012
Aspergillosis Patients Meeting Christmas Quiz December 2012
 
Aches and Pains, Everyday Moulds & Facemasks
Aches and Pains, Everyday Moulds & FacemasksAches and Pains, Everyday Moulds & Facemasks
Aches and Pains, Everyday Moulds & Facemasks
 
Latest Aspergillosis Research at NAC
Latest Aspergillosis Research at NACLatest Aspergillosis Research at NAC
Latest Aspergillosis Research at NAC
 
Some of the latest progress for the prevention, diagnosis and treatment of as...
Some of the latest progress for the prevention, diagnosis and treatment of as...Some of the latest progress for the prevention, diagnosis and treatment of as...
Some of the latest progress for the prevention, diagnosis and treatment of as...
 
Chronic Cough: What it is and how to try to reduce its impact on your life
Chronic Cough: What it is and how to try to reduce its impact on your lifeChronic Cough: What it is and how to try to reduce its impact on your life
Chronic Cough: What it is and how to try to reduce its impact on your life
 
How to give up smoking at UHSM
How to give up smoking at UHSMHow to give up smoking at UHSM
How to give up smoking at UHSM
 

Último

Axa Assurance Maroc - Insurer Innovation Award 2024
Axa Assurance Maroc - Insurer Innovation Award 2024Axa Assurance Maroc - Insurer Innovation Award 2024
Axa Assurance Maroc - Insurer Innovation Award 2024The Digital Insurer
 
Exploring the Future Potential of AI-Enabled Smartphone Processors
Exploring the Future Potential of AI-Enabled Smartphone ProcessorsExploring the Future Potential of AI-Enabled Smartphone Processors
Exploring the Future Potential of AI-Enabled Smartphone Processorsdebabhi2
 
Slack Application Development 101 Slides
Slack Application Development 101 SlidesSlack Application Development 101 Slides
Slack Application Development 101 Slidespraypatel2
 
Partners Life - Insurer Innovation Award 2024
Partners Life - Insurer Innovation Award 2024Partners Life - Insurer Innovation Award 2024
Partners Life - Insurer Innovation Award 2024The Digital Insurer
 
IAC 2024 - IA Fast Track to Search Focused AI Solutions
IAC 2024 - IA Fast Track to Search Focused AI SolutionsIAC 2024 - IA Fast Track to Search Focused AI Solutions
IAC 2024 - IA Fast Track to Search Focused AI SolutionsEnterprise Knowledge
 
08448380779 Call Girls In Diplomatic Enclave Women Seeking Men
08448380779 Call Girls In Diplomatic Enclave Women Seeking Men08448380779 Call Girls In Diplomatic Enclave Women Seeking Men
08448380779 Call Girls In Diplomatic Enclave Women Seeking MenDelhi Call girls
 
A Call to Action for Generative AI in 2024
A Call to Action for Generative AI in 2024A Call to Action for Generative AI in 2024
A Call to Action for Generative AI in 2024Results
 
CNv6 Instructor Chapter 6 Quality of Service
CNv6 Instructor Chapter 6 Quality of ServiceCNv6 Instructor Chapter 6 Quality of Service
CNv6 Instructor Chapter 6 Quality of Servicegiselly40
 
How to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected WorkerHow to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected WorkerThousandEyes
 
Finology Group – Insurtech Innovation Award 2024
Finology Group – Insurtech Innovation Award 2024Finology Group – Insurtech Innovation Award 2024
Finology Group – Insurtech Innovation Award 2024The Digital Insurer
 
The 7 Things I Know About Cyber Security After 25 Years | April 2024
The 7 Things I Know About Cyber Security After 25 Years | April 2024The 7 Things I Know About Cyber Security After 25 Years | April 2024
The 7 Things I Know About Cyber Security After 25 Years | April 2024Rafal Los
 
GenCyber Cyber Security Day Presentation
GenCyber Cyber Security Day PresentationGenCyber Cyber Security Day Presentation
GenCyber Cyber Security Day PresentationMichael W. Hawkins
 
From Event to Action: Accelerate Your Decision Making with Real-Time Automation
From Event to Action: Accelerate Your Decision Making with Real-Time AutomationFrom Event to Action: Accelerate Your Decision Making with Real-Time Automation
From Event to Action: Accelerate Your Decision Making with Real-Time AutomationSafe Software
 
2024: Domino Containers - The Next Step. News from the Domino Container commu...
2024: Domino Containers - The Next Step. News from the Domino Container commu...2024: Domino Containers - The Next Step. News from the Domino Container commu...
2024: Domino Containers - The Next Step. News from the Domino Container commu...Martijn de Jong
 
Developing An App To Navigate The Roads of Brazil
Developing An App To Navigate The Roads of BrazilDeveloping An App To Navigate The Roads of Brazil
Developing An App To Navigate The Roads of BrazilV3cube
 
Histor y of HAM Radio presentation slide
Histor y of HAM Radio presentation slideHistor y of HAM Radio presentation slide
Histor y of HAM Radio presentation slidevu2urc
 
Injustice - Developers Among Us (SciFiDevCon 2024)
Injustice - Developers Among Us (SciFiDevCon 2024)Injustice - Developers Among Us (SciFiDevCon 2024)
Injustice - Developers Among Us (SciFiDevCon 2024)Allon Mureinik
 
Salesforce Community Group Quito, Salesforce 101
Salesforce Community Group Quito, Salesforce 101Salesforce Community Group Quito, Salesforce 101
Salesforce Community Group Quito, Salesforce 101Paola De la Torre
 
TrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
TrustArc Webinar - Stay Ahead of US State Data Privacy Law DevelopmentsTrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
TrustArc Webinar - Stay Ahead of US State Data Privacy Law DevelopmentsTrustArc
 
Data Cloud, More than a CDP by Matt Robison
Data Cloud, More than a CDP by Matt RobisonData Cloud, More than a CDP by Matt Robison
Data Cloud, More than a CDP by Matt RobisonAnna Loughnan Colquhoun
 

Último (20)

Axa Assurance Maroc - Insurer Innovation Award 2024
Axa Assurance Maroc - Insurer Innovation Award 2024Axa Assurance Maroc - Insurer Innovation Award 2024
Axa Assurance Maroc - Insurer Innovation Award 2024
 
Exploring the Future Potential of AI-Enabled Smartphone Processors
Exploring the Future Potential of AI-Enabled Smartphone ProcessorsExploring the Future Potential of AI-Enabled Smartphone Processors
Exploring the Future Potential of AI-Enabled Smartphone Processors
 
Slack Application Development 101 Slides
Slack Application Development 101 SlidesSlack Application Development 101 Slides
Slack Application Development 101 Slides
 
Partners Life - Insurer Innovation Award 2024
Partners Life - Insurer Innovation Award 2024Partners Life - Insurer Innovation Award 2024
Partners Life - Insurer Innovation Award 2024
 
IAC 2024 - IA Fast Track to Search Focused AI Solutions
IAC 2024 - IA Fast Track to Search Focused AI SolutionsIAC 2024 - IA Fast Track to Search Focused AI Solutions
IAC 2024 - IA Fast Track to Search Focused AI Solutions
 
08448380779 Call Girls In Diplomatic Enclave Women Seeking Men
08448380779 Call Girls In Diplomatic Enclave Women Seeking Men08448380779 Call Girls In Diplomatic Enclave Women Seeking Men
08448380779 Call Girls In Diplomatic Enclave Women Seeking Men
 
A Call to Action for Generative AI in 2024
A Call to Action for Generative AI in 2024A Call to Action for Generative AI in 2024
A Call to Action for Generative AI in 2024
 
CNv6 Instructor Chapter 6 Quality of Service
CNv6 Instructor Chapter 6 Quality of ServiceCNv6 Instructor Chapter 6 Quality of Service
CNv6 Instructor Chapter 6 Quality of Service
 
How to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected WorkerHow to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected Worker
 
Finology Group – Insurtech Innovation Award 2024
Finology Group – Insurtech Innovation Award 2024Finology Group – Insurtech Innovation Award 2024
Finology Group – Insurtech Innovation Award 2024
 
The 7 Things I Know About Cyber Security After 25 Years | April 2024
The 7 Things I Know About Cyber Security After 25 Years | April 2024The 7 Things I Know About Cyber Security After 25 Years | April 2024
The 7 Things I Know About Cyber Security After 25 Years | April 2024
 
GenCyber Cyber Security Day Presentation
GenCyber Cyber Security Day PresentationGenCyber Cyber Security Day Presentation
GenCyber Cyber Security Day Presentation
 
From Event to Action: Accelerate Your Decision Making with Real-Time Automation
From Event to Action: Accelerate Your Decision Making with Real-Time AutomationFrom Event to Action: Accelerate Your Decision Making with Real-Time Automation
From Event to Action: Accelerate Your Decision Making with Real-Time Automation
 
2024: Domino Containers - The Next Step. News from the Domino Container commu...
2024: Domino Containers - The Next Step. News from the Domino Container commu...2024: Domino Containers - The Next Step. News from the Domino Container commu...
2024: Domino Containers - The Next Step. News from the Domino Container commu...
 
Developing An App To Navigate The Roads of Brazil
Developing An App To Navigate The Roads of BrazilDeveloping An App To Navigate The Roads of Brazil
Developing An App To Navigate The Roads of Brazil
 
Histor y of HAM Radio presentation slide
Histor y of HAM Radio presentation slideHistor y of HAM Radio presentation slide
Histor y of HAM Radio presentation slide
 
Injustice - Developers Among Us (SciFiDevCon 2024)
Injustice - Developers Among Us (SciFiDevCon 2024)Injustice - Developers Among Us (SciFiDevCon 2024)
Injustice - Developers Among Us (SciFiDevCon 2024)
 
Salesforce Community Group Quito, Salesforce 101
Salesforce Community Group Quito, Salesforce 101Salesforce Community Group Quito, Salesforce 101
Salesforce Community Group Quito, Salesforce 101
 
TrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
TrustArc Webinar - Stay Ahead of US State Data Privacy Law DevelopmentsTrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
TrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
 
Data Cloud, More than a CDP by Matt Robison
Data Cloud, More than a CDP by Matt RobisonData Cloud, More than a CDP by Matt Robison
Data Cloud, More than a CDP by Matt Robison
 

Aspergillosis Patients Support Meeting August 2011

  • 1. NICOLA SMITH NATIONAL ASPERGILLOSIS CENTRE UHSM MANCHESTER Support Meeting for Aspergillosis Patients Fungal Research Trust
  • 2. Nicola Smith The University of Manchester, Manchester Academic Health Science Centre, University Hospital of South Manchester, UK Genetic Susceptibility to Aspergillosis
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8. Gene Expression: Do the cells of aspergillosis patients respond differently to those from healthy volunteers?
  • 9.
  • 10.
  • 11. Timepoints for gene expression (1) Gene expression is measured at 30min, 1hr, 3hr, 6hr and 9hr – how does this relate to the fungus? Fungal growth: resting conidia (RC)  germinating conidia (GC)  germtube (GT)  hyphae (H) Counted the amount of fungus at each stage over time
  • 12. Timepoints for gene expression (2) Gene expression is measured at 30min, 1hr, 3hr, 6hr and 9hr – how does this relate to the fungus? 3hr – mostly resting conidia 6hr – mostly germtubes 9hr – mostly hyphae
  • 13. Method Ficoll prep PBMCs stored in liquid nitrogen Cultured for 12-15 days to differentiate to macrophages (~2x10 5 ) 24well plate – one plate per timepoint 0hr timepoint – investigate gene expression Aspergillus spores added (4x10 5 ) 30min, 1hr, 3hr, 6hr, 9hr timepoints - Investigate gene expression Macrophages and Aspergillus cultured together Heparinised Blood Macrophages PBMCs thawed and plated out (2x10 6 ) PBMCs Ficoll prepped blood Plasma Ficoll Granulocytes
  • 14. Gene Expression Results I studied the expression of 84 genes!
  • 15. RED: more expression in ABPA (2) GREEN: less expression in ABPA (12) Expression before Exposure: ABPA ABPA 0hr vs Asthma 0hr >2-fold higher expression in ABPA >2-fold lower expression in ABPA
  • 16. RED: more expression in CCPA (4) GREEN: less expression in CCPA (5) CCPA 0hr vs Healthy 0hr >2-fold higher expression in CCPA >2-fold lower expression in CCPA Expression before Exposure: CCPA
  • 17.
  • 18.
  • 19.
  • 20.
  • 21.
  • 22. Genetic Variation: Are there similar differences in the genes (DNA)?
  • 23.
  • 25.
  • 26.
  • 27.
  • 28.
  • 29.
  • 30.
  • 31.
  • 32.
  • 33.
  • 34.
  • 35.

Notas do Editor

  1. Editorial notes (Graham Atherton): Nicola worked on Chronic and allergic forms of aspergillosis, NOT invasive aspergillosis. This is partly because those are the patients groups we mainly treat here at the National Aspergillosis Centre and partly because we think that the genes that make us susceptible to invasive infection are probably quite different to those that may be making us susceptible to chronic and allergic disease.
  2. Editorial notes (Graham Atherton): There are 3 cases reported of ABPA occuring in a parent and child or in siblings – it is very rare but does weakly suggest that changes in genes may be involved There are also some small studies already done that suggest some gene changes are associated with aspergillosis Consequently we looked for any evidence of changes in how genes are switched on or off, and for changes in genes (mutations) that occur in ABPA & CPA patients
  3. Everything in our body is made up of lots of different proteins working together Different hair colour, eye colour depends on what genes you inherit from your parents
  4. Editorial notes (Graham Atherton): This is where patients’ donations are vitally important. Nicola was able to take blood samples from all volunteers (approx. 460 in all) and in each case isolate a particular group of white blood cells – the macrophages A macrophage literally eats germs such as fungal spores that you may have just breathed in. The surface of our lungs are covered in these cells, and the same cells are also present in our blood.   In order to eat germs a macrophage has to perform quite specialized tasks so it must switch particular genes on. It is normally very successful and cleans our lungs very efficiently but what about the macrophages in the lungs of ABPA patients? Are they less efficient? If so is this our first clue as to why ABPA patients cannot clean all of the fungi out of their lungs?
  5. Editorial notes (Graham Atherton): To find out Nicola performed some very sophisticated experiments were she mixed macrophages with Aspergillus spores and then looked whether dozens of genes in the macrophage were switched on or off in response to the fungus (i.e. gene expression) – replicating what happens inside our lungs. She carried this out using macrophages taken from ABPA & CPA patients and compared them with macrophages taken from uninfected people.
  6. Editorial notes (Graham Atherton): Nicola also followed the expression of the same genes before adding the Aspergillus spores and while the spores grew over the next 9 hours
  7. Editorial notes (Graham Atherton): 3 different stages of growth of the Aspergillus spores were followed: ungerminated spores at the beginning, then when they sent out their first growing tube (germtube) and then some time later (9hrs) when nearly all of the culture was taken up by the fungal mass of hyphae. At each time point different genes in the Macrophages may be turned on – it is a lot easier to eat a tiny spore (conidia) compared with a huge fungal thread (hyphae)!
  8. Editorial notes (Graham Atherton): The isolation of Macrophages from your blood is the start point of these experiments. We purify the macrophages using special tubes that are spun very fast until the different types of cells in your blood are separated out. Your cells can be used straight away or frozen to use later.
  9. Editorial notes (Graham Atherton): 84 genes were looked at. Here we see a horizontal line with columns representing genes, going upwards to indicate a gene being switched on, downwards to indicate a gene being switched off. The different colours show the levels of expression of each gene at each time it was looked at (0 to 9 hrs).
  10. Editorial notes (Graham Atherton): Red = switched on. Green = switched off. This is how the macrophage genes look before Aspergillus is added to the macrophages. These macrophages were taken from ABPA patients. 2 genes appear to be on and 15 off, though 3-4 stand out in particular.
  11. Editorial notes (Graham Atherton): Red = switched on. Green = switched off. This is how the macrophage genes look before Aspergillus is added to the macrophages. Macrophages taken from CCPA (now called CPA) patients
  12. Editorial notes (Graham Atherton): Once Aspergillus was added to the macrophages Nicola found 2 groups of genes that are switched off in ABPA & CPA patients compared with macrophages from non-ABPA/CPA people. Some genes belong to one of the major groups of genes that fight infection and others belong to a group of genes responsible for detecting infection.
  13. Editorial notes (Graham Atherton): Perhaps this is a clue or a ‘signpost’ that is pointing us towards looking at these specific groups of genes in more detail. Perhaps we have an indication here that ABPA & CCPA sufferers cannot fight off infection or cannot detect the infection as well as they should because they cannot switch on these important genes?
  14. Editorial notes (Graham Atherton): ABPA: Once the genes involved are off they stay off throughout the course of growth of Aspergillus.
  15. Editorial notes (Graham Atherton): CCPA: In one gene – TNF – the gene isn’t switched on at first but does come on more slowly than it should
  16. Editorial notes (Graham Atherton): It isn’t possible (yet) to look at all genes for every patient so we have to try to look at those for which we have some reason to suspect that they are important in the immune response to Aspergillosis. The work Nicola had already carried out has, as we have already explained, identified several groups of genes that are switched off in ABPA & CPA patients. These are therefore a good place to start so Nicola has been looking at the DNA sequence of the genes highlighted by that research.
  17. Editorial notes (Graham Atherton): Several genes do show changes in CCPA, ABPA and SAFS patients. In all cases those small changes could have one or several effects including changes in how the protein coded for by the gene does its job and changes in whether the gene is switched on or off. In several cases here we can see genes associated with CCPA and ABPA that are switched off or are on only at very low levels – so perhaps here is a clue that the small change in DNA sequence in those genes might also be causing the gene to be switched off?
  18. Editorial notes (Graham Atherton):
  19. Editorial notes (Graham Atherton):
  20. Editorial notes (Graham Atherton): CONCLUSIONS   Nicola’s work has shown us that we can detect differences between the way genes are switched on & off in response to Aspergillus ‘infection’ in the laboratory and in the DNA sequences of genes when comparing macrophages taken from ABPA & CPA/CCPA patients with those taken from people who do not suffer from those infections. Those changes fall into groups of genes known to be involved in our immune systems and in how we detect infections. This suggests that the genes we have detected could be directly involved in fighting off infection. Given that one of the things chronic aspergillosis patients cannot do is fight off infection by Aspergillus we are encouraged that we are working along the right lines and are going about this research using the right methods to get meaningful results.   As yet all we had demonstrated is that some genes are controlled differently in chronic aspergillosis patients and some mutations are more frequent in the same patient group compared with non-infected people. This ISN’T the same as showing that these genes and mutations are responsible for ABPA & CPA as there are still several other possible explanations – for example we could as easily argue that the changes in the levels of gene expression in ABPA patients is caused BY ABPA rather than causing ABPA! An illustrative example might be that we have done the equivalent of demonstrating that your nose runs when you have a cold – we cannot conclude that a runny nose causes a cold BUT it does point us in the right direction to finding out if it does.   Consequently we cannot yet say that susceptibility to aspergillosis is an inherited trait. There have been 3 cases reported but in all cases you could just as easily state that as they will have been brought up in the same house & environment and that may have been the cause of their ABPA rather than them having similar genes. No clarifying work has been done on the cases mentioned (the work was carried out in India) so we do not know if there are common DNA changes etc.   Even if we do show at some point in the future that some gene differences can make a person susceptible to infection, it is very likely that these gene differences will be rare and usually present with other genes that compensate for them in some way so as to reduce their effect. Only on rare occasions will enough ‘susceptibility genes’ come together in an individual to make them vulnerable to ABPA or CPA, and even then they would need the right conditions to actually become infected e.g. CPA normally needs a prior infection such as TB. If this were not the case then ABPA & CPA would be much more common.  
  21. Editorial notes (Graham Atherton): For the future we now have several candidate genes on which to do further research thanks to Nicola’s work and the amazing generosity of every patient who donated a sample of blood.   Graham Atherton 5/8/2011